1. Yagoda, A.: Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.Cancer Res., 37, 2775 (1977).
2. Soloway, M. S., Ikard, M., Ford, K.: Cis-diaminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer.Cancer, 47, 476 (1981).
3. Merrin, C. E.: Treatment of genitourinary tumours with cis-Dichlorodiamineplatinum(II): experience in 250 patients.Cancer Treat. Rep., 63, 1579 (1979).
4. Von Hoff, D. D., Schilsky, R., Reichert, C. M., Reddick, R. L., Rozencweig, M., Young, R. C., Muggia, F. M.: Toxic effects of cis-Dichlorodiamineplatinum(II) in man.Cancer Treat. Rep., 63, 1527 (1979).
5. Blachle, J. D., Hill, J. B.: Renal and electrolyte disturbances associated with Cisplatin.Ann. Int. Med., 95, 628 (1981).